Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 61.07 |
| Open | 61.51 |
| Bid | 60.18 x 800 |
| Ask | 60.26 x 800 |
| Day's range | 59.62 - 62.11 |
| 52-week range | 59.62 - 170.47 |
| Volume | |
| Avg. volume | 4,671,087 |
| Market cap | 23.141B |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Jim Cramer stocks that finished dead last. In a recent episode of Mad Money, Jim Cramer examined market trends of the […]
- Investor's Business Daily
Is Moderna Stock A Sell After The Company Slashed Its R&D Budget?
Moderna stock tumbled after the company issued a light 2025 sales outlook and cut its 2027 R&D budget. Is MRNA stock a sell?
- Zacks
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared with treatment with Comirnaty.
© 2024 Yahoo. All rights reserved.